Buy Rating for Surgery Partners: Strong Revenue Growth, Strategic Developments, and Market Opportunities
PremiumRatingsBuy Rating for Surgery Partners: Strong Revenue Growth, Strategic Developments, and Market Opportunities
1M ago
Surgery Partners price target lowered to $35 from $40 at Benchmark
Premium
The Fly
Surgery Partners price target lowered to $35 from $40 at Benchmark
1M ago
Surgery Partners Reports Strong Revenue Growth for 2024
Premium
Company Announcements
Surgery Partners Reports Strong Revenue Growth for 2024
1M ago
SGRY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsSGRY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
BofA moves to No Rating on Surgery Partners after Bain offer
Premium
The Fly
BofA moves to No Rating on Surgery Partners after Bain offer
2M ago
Surgery Partners says committee to review $25.75 per share buyout proposal
Premium
The Fly
Surgery Partners says committee to review $25.75 per share buyout proposal
2M ago
Surgery Partners price target lowered to $35 from $49 at RBC Capital
PremiumThe FlySurgery Partners price target lowered to $35 from $49 at RBC Capital
5M ago
Surgery Partners post-earnings selloff overdone, says Macquarie
Premium
The Fly
Surgery Partners post-earnings selloff overdone, says Macquarie
5M ago
Surgery Partners price target lowered to $31 from $32 at Barclays
Premium
The Fly
Surgery Partners price target lowered to $31 from $32 at Barclays
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100